Gemzar and disseminated intravascular coagulation Patient Reports February 13, 2012

Gemzar Side Effects Report #5864410-8
Gemzar side effect was reported by a Physician from JAPAN on Aug 18, 2008. Male patient, 69 years of age, was diagnosed with transitional cell cancer of the renal pelvis and ureter recurrent, metastases to central nervous system and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone marrow failure, disseminated intravascular coagulation, intestinal ischaemia, metastases to central nervous system, metastases to liver, metastases to lung. Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN, THERAPEUTIC RADIOPHARMACEUTICALS. Patient died on 06/27/2006.

Gemzar Side Effects Report #6069798-3
Gemzar side effect was reported by a Physician from JAPAN on Feb 05, 2009. Female patient, 76 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, gastric ulcer haemorrhage, shock haemorrhagic. Gemzar dosage: unknown. During the same period patient was treated with PARIET. Patient died on 01/10/2009.

Gemzar Side Effects Report #4855684-0
Gemzar side effect was reported by a Physician from JAPAN on Nov 29, 2005. Male patient, 74 years of age, weighting 112.4 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure, cardiomegaly, cholangitis acute, condition aggravated, disseminated intravascular coagulation, jaundice , malignant neoplasm progression, pancreatic carcinoma, pleural effusion. Gemzar dosage: unknown. During the same period patient was treated with OMEPRAL, PRIMPERAN, AMLODIN, MAGLAX, LAXOBERON, GASMOTIN. Patient was hospitalized. Patient died on 08/08/2004.

Gemzar Side Effects Report #4871137-8
Gemzar side effect was reported by a Health Professional from JAPAN on Dec 15, 2005. Male patient, 74 years of age, weighting 112.4 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiac failure, cholangitis acute, disseminated intravascular coagulation, malignant neoplasm progression, pancreatic carcinoma, pleural effusion, pneumonitis, renal failure. Gemzar dosage: unknown. During the same period patient was treated with OMEPRAZOLE, PRIMPERAN, AMLODIPINE BESYLATE, MAGLAX, LAXOBERON, GASMOTIN. Patient was hospitalized. Patient died on 08/08/2004.


Gemzar Side Effects Report #4939268-1
Gemzar side effect was reported by a Physician from JAPAN on Feb 17, 2006. Female patient, 70 years of age, weighting 138.9 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain , blood pressure decreased, cardiac murmur, disseminated intravascular coagulation, fluid intake reduced, gastrointestinal disorder, pneumonia , rhinorrhoea, sepsis . Gemzar dosage: unknown. Patient was hospitalized. Patient died on 01/23/2006.

Gemzar Side Effects Report #4950019-7
Gemzar side effect was reported by a Physician from JAPAN on Feb 27, 2006. Female patient, 70 years of age, weighting 138.9 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: atelectasis, blood fibrinogen increased, blood pressure decreased, bone marrow failure, disseminated intravascular coagulation, fluid intake reduced, nausea , pneumonia , rhinorrhoea. Gemzar dosage: 800 MG, OTHER, INTRAVENOUS; 1000 MG, OTHER, INTRAVENOUS; 1200 MG, OTHER, INTRAVENOUS. Patient died on 01/23/2006.

Gemzar Side Effects Report #4680548-5
Gemzar side effect was reported by a Physician from on May 12, 2005. Male patient, 68 years of age, weighting 112.4 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, bacterial infection , biliary tract infection, bone marrow depression, disseminated intravascular coagulation, inflammation, liver abscess, pleural effusion, sepsis . Gemzar dosage: 1200 MG OTHER. During the same period patient was treated with NIZATIDINE, GASTROM, GASMOTIN, LENDORM, SULPERAZON, URSODIOL, ZOFRAN, VOLTAREN. Patient died on 11/15/2002.

Gemzar Side Effects Report #5499338-9
Gemzar side effect was reported by a Physician from JAPAN on Oct 17, 2007. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, endocarditis . Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5520488-2
Gemzar side effect was reported by a Physician from JAPAN on Nov 07, 2007. Male patient, 63 years of age, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, endocarditis . Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.


Gemzar Side Effects Report #5224275-4
Gemzar side effect was reported by a Physician from JAPAN on Jan 22, 2007. Female patient, 57 years of age, weighting 87.52 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis, nausea , pain , constipation , insomnia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, bone marrow failure, disseminated intravascular coagulation, pneumonia , septic shock. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with CISPLATIN, GASTER D, FOIPAN, GASMOTIN, LOXONIN, MAGNESIUM OXIDE, TOFRANIL. Patient died on 12/13/2006.

Gemzar Side Effects Report #5237515-2
Gemzar side effect was reported by a Physician from JAPAN on Feb 05, 2007. Female patient, 57 years of age, weighting 87.52 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis, nausea , pain , constipation , insomnia and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, bone marrow failure, disseminated intravascular coagulation, pneumonia , septic shock. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with CISPLATIN, GASTER D, FOIPAN, GASMOTIN, LOXONIN, MAGNESIUM OXIDE, TOFRANIL. Patient died on 12/13/2006.

Gemzar Side Effects Report #4822119-3
Gemzar side effect was reported by a Physician from JAPAN on Oct 19, 2005. Female patient, 55 years of age, weighting 121.3 lb, was diagnosed with pancreatic carcinoma stage iv and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood pressure decreased, bone marrow failure, disseminated intravascular coagulation, pyrexia, respiratory failure. Gemzar dosage: 1200 MG OTHER. During the same period patient was treated with LAMIVUDINE, URSODIOL, OMEPRAZOLE, BIO THREE. Patient died on 09/04/2005.

Gemzar Side Effects Report #5823488-8
Gemzar side effect was reported by a Physician from JAPAN on July 16, 2008. Male patient, weighting 112.0 lb, was diagnosed with pancreatic carcinoma stage iv, diabetes mellitus and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, metastases to large intestine, metastases to lung, metastases to peritoneum. Gemzar dosage: 1600 MG, OTHER. During the same period patient was treated with BASEN. Patient died on 06/08/2008.

Gemzar Side Effects Report #6104012-1
Gemzar side effect was reported by a Physician from JAPAN on Mar 02, 2009. Female patient, weighting 105.8 lb, was diagnosed with pancreatic carcinoma stage iv, prophylaxis against gastrointestinal ulcer, constipation , cancer pain and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, gastric ulcer haemorrhage, metastases to liver, platelet count decreased, shock haemorrhagic, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with PARIET, MAGMITT, FENTANYL, GASMOTIN. Patient died on 01/10/2009.


Gemzar Side Effects Report #5170023-6
Gemzar side effect was reported by a Physician from JAPAN on Nov 29, 2006. Female patient, 70 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, necrotising fasciitis, neoplasm progression, pneumonia . Gemzar dosage: unknown. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5678649-8
Gemzar side effect was reported by a Physician from JAPAN on Mar 11, 2008. Female patient, 70 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: candida pneumonia, disseminated intravascular coagulation, necrotising fasciitis, neoplasm progression, sepsis . Gemzar dosage: 400 MG, OTHER. During the same period patient was treated with THERAPEUTIC RADIOPHARMACEUTICALS. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5197079-9
Gemzar side effect was reported by a Physician from JAPAN on Dec 20, 2006. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, disseminated intravascular coagulation, liver abscess, sepsis , shock, vascular pseudoaneurysm. Gemzar dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5219019-6
Gemzar side effect was reported by a Physician from JAPAN on Jan 17, 2007. Male patient, 65 years of age, was diagnosed with pancreatic carcinoma non-resectable and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, disseminated intravascular coagulation, hypoproteinaemia, liver abscess, sepsis , shock, vascular pseudoaneurysm, white blood cell count decreased. Gemzar dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4620267-4
Gemzar side effect was reported by a Physician from on Mar 04, 2005. Male patient, 78 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, renal failure. Gemzar dosage: unknown. Patient recovered.


Gemzar Side Effects Report #5931593-0
Gemzar side effect was reported by a Physician from JAPAN on Oct 15, 2008. Male patient, 77 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: ascites, cholangitis, disseminated intravascular coagulation, hepatic atrophy, malaise, osteitis, portal vein occlusion, renal failure acute. Gemzar dosage: unknown. Patient died on 05/10/2007.

Gemzar Side Effects Report #5062446-0
Gemzar side effect was reported by a Physician from JAPAN on July 04, 2006. Male patient, 76 years of age, weighting 124.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral infarction, disseminated intravascular coagulation, respiratory failure, tumour lysis syndrome. Gemzar dosage: 1400 MG, OTHER, INTRAVENOUS. During the same period patient was treated with OXYCONTIN, FAMOTIDINE, FOIPAN, MINIPRESS, MEVALOTIN, DEPASS, PANTOSIN, MAGNESIUM OXIDE. Patient died on 12/18/2005.

Gemzar Side Effects Report #4928069-6
Gemzar side effect was reported by a Physician from JAPAN on Feb 01, 2006. Male patient, 76 years of age, weighting 124.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral infarction, disseminated intravascular coagulation, hemiparesis. Gemzar dosage: 1400 MG, OTHER, INTRAVENOUS. During the same period patient was treated with OXYCONTIN, FAMOTIDINE, FOIPAN, MINIPRESS, PRAVASTATIN, DEPAS, PANTOSIN, MAGNESIUM OXIDE. Patient died on 12/18/2005.

Gemzar Side Effects Report #4956242-X
Gemzar side effect was reported by a Physician from JAPAN on Mar 10, 2006. Male patient, 76 years of age, weighting 124.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: autonomic failure syndrome, cerebral infarction, disseminated intravascular coagulation, pancreatic carcinoma, respiratory failure. Gemzar dosage: 1400 MG, OTHER, INTRAVENOUS. During the same period patient was treated with OXYCONTIN, FAMOTIDINE, FOIPAN, MINIPRESS, PRAVASTATIN, DEPAS, PANTOSIN, MAGNESIUM OXIDE. Patient died on 12/18/2005.

Gemzar Side Effects Report #4975556-0
Gemzar side effect was reported by a Physician from JAPAN on Mar 22, 2006. Male patient, 76 years of age, weighting 124.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cerebral infarction, disseminated intravascular coagulation, dysphagia, respiratory failure. Gemzar dosage: 1400 MG, OTHER, INTRAVENOUS. During the same period patient was treated with OXYCONTIN, FAMOTIDINE, FOIPAN, MINIPRESS, MEVALOTIN, DEPAS, PANTOSIN, MAGNESIUM OXIDE. Patient died on 12/18/2005.


Gemzar Side Effects Report #5197098-2
Gemzar side effect was reported by a Physician from JAPAN on Dec 21, 2006. Female patient, 73 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: carcinoembryonic antigen increased, disseminated intravascular coagulation, jaundice cholestatic, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient died on 01/01/2005.

Gemzar Side Effects Report #5261054-6
Gemzar side effect was reported by a Physician from JAPAN on Feb 26, 2007. Female patient, 73 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: carcinoembryonic antigen increased, disseminated intravascular coagulation, jaundice cholestatic, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with FLUOROURACIL. Patient was hospitalized. Patient died on 01/01/2005.

Gemzar Side Effects Report #4629900-4
Gemzar side effect was reported by a Physician from on Mar 23, 2005. Male patient, 72 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation. Gemzar dosage: 1400 MG OTHER. Patient recovered.

Gemzar Side Effects Report #4648424-1
Gemzar side effect was reported by a Physician from on Apr 07, 2005. Male patient, 72 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anaemia, disseminated intravascular coagulation, haemolytic uraemic syndrome. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with SULPERAZON, KYTRIL, DECADRON. Patient recovered.

Gemzar Side Effects Report #4655900-4
Gemzar side effect was reported by a Physician from on Apr 20, 2005. Male patient, 72 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: catheter site haemorrhage, disseminated intravascular coagulation, haemolytic anaemia, haemolytic uraemic syndrome, liver disorder. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with SULPERAZON, KYTRIL, DECADRON. Patient recovered.


Gemzar Side Effects Report #4662767-7
Gemzar side effect was reported by a Physician from on Apr 20, 2005. Male patient, 72 years of age, weighting 114.6 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: catheter site haemorrhage, condition aggravated, disseminated intravascular coagulation, haemoglobin decreased, haemolytic anaemia, haemolytic uraemic syndrome, haemorrhagic diathesis, international normalised ratio increased, liver disorder. Gemzar dosage: 1400 MG OTHER. During the same period patient was treated with KYTRIL, DECADRON, SULPERAZON. Patient recovered.

Gemzar Side Effects Report #4770912-8
Gemzar side effect was reported by a Physician from JAPAN on Aug 29, 2005. Male patient, 72 years of age, weighting 154.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: biliary tract infection, condition aggravated, disseminated intravascular coagulation, rash . Gemzar dosage: 200 MG OTHER. During the same period patient was treated with CLINDAMYCIN, ROCEPHIN, MIRACLID, ANTITHROMBIN III. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4776367-1
Gemzar side effect was reported by a Physician from JAPAN on Sept 05, 2005. Male patient, 72 years of age, weighting 154.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: biliary tract infection, c-reactive protein increased, condition aggravated, disseminated intravascular coagulation, haemorrhage, international normalised ratio increased, platelet count decreased, prothrombin time prolonged, pyrexia. Gemzar dosage: 200 MG OTHER. During the same period patient was treated with CLINDAMYCIN, ROCEPHIN, MIRACLID, ANTITHROMBIN III. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5239766-X
Gemzar side effect was reported by a Physician from JAPAN on Feb 06, 2007. Male patient, 71 years of age, weighting 138.9 lb, was diagnosed with pancreatic carcinoma, pain  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, bile duct stenosis, bone marrow failure, disseminated intravascular coagulation, interstitial lung disease, malaise, malignant neoplasm progression, nausea , oedema. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with OMEPRAL, CAMOSTAT MESILATE, FUROSEMIDE, PENTAGIN, MAGMITT. Patient was hospitalized. Patient died on 10/29/2006.

Gemzar Side Effects Report #5062437-X
Gemzar side effect was reported by a Physician from JAPAN on July 04, 2006. Female patient, 60 years of age, weighting 110.2 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: anorexia, ascites, blood pressure decreased, cardiac disorder, cardiac failure, cerebral infarction, disseminated intravascular coagulation, mouth breathing, multi-organ failure. Gemzar dosage: 1400 MG DAILY (1/D) INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, ZOFRAN, KADIAN. Patient died on 04/28/2002.


Gemzar Side Effects Report #5706567-5
Gemzar side effect was reported by a Physician from FRANCE on Apr 03, 2008. Male patient, 56 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholecystitis, disseminated intravascular coagulation, interstitial lung disease, thrombocytopenia. Gemzar dosage: 1970 MG, OTHER. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5796161-2
Gemzar side effect was reported by a Physician from FRANCE on June 17, 2008. Male patient, 56 years of age, weighting 156.5 lb, was diagnosed with pancreatic carcinoma, escherichia bacteraemia, depression , pain  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cholecystitis, disseminated intravascular coagulation, dyspnoea, interstitial lung disease, thrombocytopenia. Gemzar dosage: 1970 MG, ON DAY 1, 8 AND 15 OF 4 WEEKLY CYCLES. During the same period patient was treated with CLAMOXYL, SEROPLEX, SKENAN, OFLOCET. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4714125-4
Gemzar side effect was reported by a Physician from JAPAN on June 23, 2005. Female patient, 55 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain , acute respiratory distress syndrome, anorexia, bacteria blood identified, catheter sepsis, condition aggravated, depressed level of consciousness, disseminated intravascular coagulation, septic shock. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #4806953-1
Gemzar side effect was reported by a Physician from JAPAN on Sept 30, 2005. Female patient, 55 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood pressure decreased, bone marrow failure, disseminated intravascular coagulation, respiratory failure. Gemzar dosage: 800 MG/M2 OTHER. During the same period patient was treated with ROCEPHIN, LAMIVUDINE. Patient died on 09/01/2005.

Gemzar Side Effects Report #4824598-4
Gemzar side effect was reported by a Physician from JAPAN on Oct 19, 2005. Female patient, 55 years of age, weighting 121.3 lb, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood pressure decreased, bone marrow failure, disseminated intravascular coagulation, pyrexia, respiratory failure. Gemzar dosage: 1200 MG OTHER. During the same period patient was treated with LAMIVUDINE, URSODIOL, OMEPRAZOLE, BIO THREE. Patient died on 09/04/2005.


Gemzar Side Effects Report #4848041-4
Gemzar side effect was reported by a Physician from JAPAN on Nov 17, 2005. Female patient, 55 years of age, was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: abdominal pain , acute respiratory distress syndrome, anorexia, blood culture positive, catheter sepsis, depressed level of consciousness, disseminated intravascular coagulation, oliguria. Gemzar dosage: unknown. Patient was hospitalized. Patient recovered.

Gemzar Side Effects Report #5388358-0
Gemzar side effect was reported by a Physician from JAPAN on July 05, 2007. Male patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood alkaline phosphatase increased, disseminated intravascular coagulation, jaundice , malignant neoplasm progression, platelet count decreased. Gemzar dosage: 1550 MG, OTHER. Patient recovered.

Gemzar Side Effects Report #5786059-8
Gemzar side effect was reported by a Physician from JAPAN on June 12, 2008. Female patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, platelet count decreased, renal failure, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with PROTECADIN, WARFARIN, URSO, LOXONIN, STARSIS, PRIMPERAN, ZOFRAN. Patient died on 11/04/2007.

Gemzar Side Effects Report #6085635-5
Gemzar side effect was reported by a Physician from JAPAN on Feb 18, 2009. Female patient was diagnosed with pancreatic carcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, no therapeutic response, renal failure, white blood cell count decreased. Gemzar dosage: 1000 MG, OTHER. During the same period patient was treated with PROTECADIN, WARFARIN, URSO, LOXONIN, STARSIS, PRIMPERAN, ZOFRAN. Patient died on 11/04/2007.

Gemzar Side Effects Report #4618586-0
Gemzar side effect was reported by a Physician from on Mar 08, 2005. Male patient, 75 years of age, weighting 116.8 lb, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anuria, blood lactate dehydrogenase increased, depressed level of consciousness, diffuse alveolar damage, disseminated intravascular coagulation, emphysema, infection in an immunocompromised host. Gemzar dosage: 1500 MG. During the same period patient was treated with NORMAL SALINE, TRANSAMIN, NAUZELIN, LAXOBERON, MS CONTIN, STEIROCALL, ZOFRAN, ALENDRONATE. Patient was hospitalized. Patient died on 11/05/2000.

Gemzar Side Effects Report #4971463-8
Gemzar side effect was reported by a Physician from JAPAN on Mar 23, 2006. Male patient, 71 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, disseminated intravascular coagulation, malignant ascites, malignant neoplasm progression, non-small cell lung cancer, septic shock, white blood cell count decreased. Gemzar dosage: 1000 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with OXYCONTIN. Patient died on 12/11/2005.

Gemzar Side Effects Report #4982561-7
Gemzar side effect was reported by a Physician from UNITED STATES on Apr 10, 2006. Female patient, 65 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation. Gemzar dosage: 1250 MG/M2, OTHER. During the same period patient was treated with CARBOPLATIN. Patient died on 04/09/2006.

Gemzar Side Effects Report #6062294-9
Gemzar side effect was reported by a Physician from JAPAN on Jan 30, 2009. Male patient, 57 years of age, was diagnosed with non-small cell lung cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, malignant neoplasm progression, pyrexia, white blood cell count increased. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CISPLATIN. Patient died on 01/30/2009.

Gemzar Side Effects Report #5879485-X
Gemzar side effect was reported by a Physician from JAPAN on Aug 29, 2008. Male patient, 74 years of age, weighting 136.7 lb, was diagnosed with lung squamous cell carcinoma stage iii, cerebral infarction, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute myocardial infarction, anaemia, disseminated intravascular coagulation, interstitial lung disease, pneumocystis jiroveci pneumonia, pneumonia cytomegaloviral, pulmonary alveolar haemorrhage, renal impairment. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with NAVELBINE, ASPIRIN, KYTRIL. Patient died on 08/29/2008.

Gemzar Side Effects Report #4607612-0
Gemzar side effect was reported by a Physician from on Feb 18, 2005. Male patient, 68 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, atelectasis, clostridium colitis, disseminated intravascular coagulation, lymphangiosis carcinomatosa, pneumonia staphylococcal, pulmonary alveolar haemorrhage, pulmonary oedema. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died on 01/21/2005.


Gemzar Side Effects Report #4618593-8
Gemzar side effect was reported by a Physician from on Mar 09, 2005. Male patient, 68 years of age, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, anaemia, atelectasis, blood product transfusion, clostridium colitis, disseminated intravascular coagulation, lung neoplasm malignant, malignant neoplasm progression, packed red blood cell transfusion. Gemzar dosage: unknown. During the same period patient was treated with CARBOPLATIN. Patient was hospitalized. Patient died on 01/21/2005.

Gemzar Side Effects Report #4860901-7
Gemzar side effect was reported by a Physician from JAPAN on Dec 06, 2005. Female patient, 64 years of age, weighting 72.75 lb, was diagnosed with lung neoplasm malignant and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, bone marrow failure, disseminated intravascular coagulation, pneumonia , septic shock. Gemzar dosage: 900 MG, OTHER, INTRAVENOUS. During the same period patient was treated with NAVELBINE, RANITIDINE HYDROCHLORIDE, DISOPYRAMIDE, MAGNESIUM OXIDE, AZULENE, DEXAMETHASONE, ASPIRIN, METOCLOPRAMIDE. Patient recovered.

Gemzar Side Effects Report #5878937-6
Gemzar side effect was reported by a Physician from JAPAN on Aug 28, 2008. Male patient, 64 years of age, weighting 103.6 lb, was diagnosed with lung adenocarcinoma stage iv, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: arteritis, cough, disseminated intravascular coagulation, local swelling, malaise, multi-organ failure, platelet count decreased, pneumonia , pyrexia. Gemzar dosage: 1400 MG, OTHER. During the same period patient was treated with PARAPLATIN, DECADRON, KYTRIL. Patient died on 07/12/2008.

Gemzar Side Effects Report #5062531-3
Gemzar side effect was reported by a Physician from JAPAN on July 07, 2006. Male patient, 71 years of age, was diagnosed with lung adenocarcinoma stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone marrow failure, decreased appetite, disseminated intravascular coagulation, gait disturbance, hepatic failure, lymphadenopathy, nausea , pain . Gemzar dosage: 1500 MG, OTHER, INTRAVENOUS. During the same period patient was treated with PARAPLATIN. Patient died on 09/16/2003.

Gemzar Side Effects Report #5109616-0
Gemzar side effect was reported by a Physician from JAPAN on Sept 04, 2006. Male patient, 71 years of age, was diagnosed with lung adenocarcinoma stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: bone marrow failure, decreased appetite, disseminated intravascular coagulation, gait disturbance, hepatic failure, lymphadenopathy, nausea , pain . Gemzar dosage: 1500 MG, OTHER, INTRAVENOUS. During the same period patient was treated with PARAPLATIN. Patient died on 09/16/2003.

Gemzar Side Effects Report #4746416-5
Gemzar side effect was reported by a Physician from JAPAN on Aug 01, 2005. Male patient, 70 years of age, weighting 134.5 lb, was diagnosed with lung adenocarcinoma stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiomegaly, disseminated intravascular coagulation, lung disorder, pulmonary congestion, pulmonary oedema. Gemzar dosage: 1500 MG OTHER. During the same period patient was treated with KYTRIL, MAXIPIME, MUCODYNE. Patient died on 04/29/2005.

Gemzar Side Effects Report #4994195-9
Gemzar side effect was reported by a Physician from JAPAN on Apr 19, 2006. Male patient, 51 years of age, weighting 140.7 lb, was diagnosed with lung adenocarcinoma stage iii and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood pressure decreased, candidiasis, disseminated intravascular coagulation, enterococcal infection, pancreatic necrosis, pleural effusion, pneumonitis, pulmonary alveolar haemorrhage, rash . Gemzar dosage: 1700 MG, OTHER, INTRAVENOUS. During the same period patient was treated with CARBOPLATIN. Patient died on 12/16/2003.

Gemzar Side Effects Report #4681907-7
Gemzar side effect was reported by a Physician from on May 16, 2005. Male patient, 70 years of age, weighting 134.5 lb, was diagnosed with lung adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiomegaly, disseminated intravascular coagulation, lung disorder, po2 decreased, pulmonary congestion. Gemzar dosage: 1500 MG OTHER. During the same period patient was treated with KYTRIL INFUSION, MAXIPIME, MUCODYNE, OPSO. Patient died on 04/29/2005.

Gemzar Side Effects Report #4687023-2
Gemzar side effect was reported by a Physician from on May 25, 2005. Male patient, 70 years of age, weighting 134.5 lb, was diagnosed with lung adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cardiomegaly, chest x-ray abnormal, disseminated intravascular coagulation, lung disorder, oxygen saturation decreased, pulmonary congestion. Gemzar dosage: 1500 MG OTHER. During the same period patient was treated with KYTRIL, MAXIPIME, MUCODYNE, OPSO. Patient died on 04/29/2005.

Gemzar Side Effects Report #4710741-4
Gemzar side effect was reported by a Physician from JAPAN on June 21, 2005. Male patient, 51 years of age, weighting 141.1 lb, was diagnosed with lung adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory failure, bacteria sputum identified, blood pressure decreased, candidiasis, disseminated intravascular coagulation, enterococcal infection, fungus sputum test positive, haemoptysis. Gemzar dosage: 1700 MG OTHER. During the same period patient was treated with CARBOPLATIN. Patient died on 12/16/2003.


Gemzar Side Effects Report #4714060-1
Gemzar side effect was reported by a Physician from JAPAN on June 22, 2005. Female patient, 51 years of age, weighting 141.1 lb, was diagnosed with lung adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: blood pressure decreased, candida pneumonia, disseminated intravascular coagulation, enterococcal infection, legionella serology positive, pancreatic necrosis, pleural effusion, pneumonitis. Gemzar dosage: 1700 MG OTHER. During the same period patient was treated with CARBOPLATIN. Patient died on 12/16/2003.

Gemzar Side Effects Report #4738534-2
Gemzar side effect was reported by a Physician from JAPAN on July 07, 2005. Male patient, 51 years of age, weighting 141.1 lb, was diagnosed with lung adenocarcinoma and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory failure, acute stress disorder, blood pressure diastolic decreased, candidiasis, condition aggravated, crackles lung, disseminated intravascular coagulation, enterococcal infection, haemoptysis. Gemzar dosage: 1700 MG OTHER. During the same period patient was treated with CARBOPLATIN. Patient died on 12/16/2003.

Gemzar Side Effects Report #5697132-7
Gemzar side effect was reported by a Physician from JAPAN on Mar 28, 2008. Female patient, 70 years of age, weighting 103.6 lb, was diagnosed with gastric cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: carbohydrate antigen 19-9 increased, disseminated intravascular coagulation, nausea . Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with CISPLATIN. Patient died on 04/01/2005.

Gemzar Side Effects Report #4988634-7
Gemzar side effect was reported by a Physician from JAPAN on Apr 12, 2006. Female patient, 70 years of age, was diagnosed with gastric cancer recurrent and was treated with Gemzar. After drug was administered, patient experienced the following side effects: cancer pain, carbohydrate antigen 19-9 increased, condition aggravated, disseminated intravascular coagulation, metastases to bone marrow, metastatic gastric cancer, nausea . Gemzar dosage: unknown. During the same period patient was treated with CISPLATIN. Patient died on 04/01/2005.

Gemzar Side Effects Report #5496467-0
Gemzar side effect was reported by a Physician from JAPAN on Oct 12, 2007. Female patient, weighting 114.6 lb, was diagnosed with gallbladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute coronary syndrome, atrioventricular block complete, disseminated intravascular coagulation, malignant neoplasm progression. Gemzar dosage: 800 MG, OTHER. Patient died on 07/23/2007.

Gemzar Side Effects Report #5566685-1
Gemzar side effect was reported by a Physician from JAPAN on Dec 13, 2007. Female patient, weighting 114.6 lb, was diagnosed with gallbladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute coronary syndrome, atrioventricular block complete, disseminated intravascular coagulation, malignant neoplasm progression. Gemzar dosage: 800 MG, OTHER. Patient died on 07/23/2007.

Gemzar Side Effects Report #5712581-6
Gemzar side effect was reported by a Physician from JAPAN on Apr 11, 2008. Female patient was diagnosed with gallbladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, thrombocytopenia. Gemzar dosage: 1400 MG, OTHER. Patient died on 01/01/2008.

Gemzar Side Effects Report #5728819-5
Gemzar side effect was reported by a Physician from JAPAN on Apr 28, 2008. Female patient, weighting 121.3 lb, was diagnosed with gallbladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, haemoglobin decreased, malignant neoplasm progression. Gemzar dosage: 1400 MG, OTHER. Patient died on 03/27/2008.

Gemzar Side Effects Report #5728823-7
Gemzar side effect was reported by a Physician from UNITED KINGDOM on Apr 28, 2008. Female patient, 45 years of age, was diagnosed with breast cancer metastatic and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, pneumonitis. Gemzar dosage: unknown. During the same period patient was treated with AVASTIN. Patient recovered.

Gemzar Side Effects Report #5033760-X
Gemzar side effect was reported by a Physician from JAPAN on June 06, 2006. Male patient, 78 years of age, was diagnosed with bladder cancer  and was treated with Gemzar. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, bone marrow failure, capillary leak syndrome, cardiac arrest , cerebral infarction, disseminated intravascular coagulation, pleural effusion, respiratory failure. Gemzar dosage: 2500 MG/M2, OTHER, INTRAVENOUS. During the same period patient was treated with PACLITAXEL. Patient died on 05/12/2006.


Gemzar Side Effects Report #6132209-3
Gemzar side effect was reported by a Physician from JAPAN on Mar 18, 2009. Male patient, 72 years of age, was diagnosed with bile duct cancer and was treated with Gemzar. After drug was administered, patient experienced the following side effects: altered state of consciousness, disseminated intravascular coagulation, liver abscess, liver disorder, sepsis , subdiaphragmatic abscess. Gemzar dosage: unknown. During the same period patient was treated with FLUOROURACIL. Patient recovered.

Gemzar Side Effects Report #5715980-1
Gemzar side effect was reported by a Physician from JAPAN on Apr 15, 2008. Female patient, weighting 110.2 lb, was diagnosed with bile duct cancer, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, metastases to lung. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with SEROTONE, DECADRON, RINDERON, MYSLEE, THYRADIN S, LOXONIN, CYTOTEC, LANSOPRAZOLE. Patient died on 01/04/2008.

Gemzar Side Effects Report #5740447-4
Gemzar side effect was reported by a Physician from JAPAN on May 08, 2008. Female patient, weighting 110.2 lb, was diagnosed with bile duct cancer, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, metastases to lung, metastases to peritoneum. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with SEROTONE, DECADRON, RINDERON, MYSLEE, THYRADIN S, LOXONIN, CYTOTEC, TAKEPRON. Patient died on 01/04/2008.

Gemzar Side Effects Report #5759612-5
Gemzar side effect was reported by a Physician from JAPAN on May 27, 2008. Female patient, weighting 110.2 lb, was diagnosed with bile duct cancer, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, metastases to lung, metastases to peritoneum. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with SEROTONE, DECADRON, RINDERON, MYSLEE, LEVOTHYROXINE, LOXONIN, CYTOTEC, LANSOPRAZOLE. Patient died on 01/04/2008.

Gemzar Side Effects Report #5891698-X
Gemzar side effect was reported by a Physician from JAPAN on May 27, 2008. Female patient, weighting 110.2 lb, was diagnosed with bile duct cancer, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, metastases to lung, metastases to peritoneum. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with SEROTONE, DECADRON, RINDERON, MYSLEE, LEVOTHYROXINE, LOXONIN, CYTOTEC, LANSOPRAZOLE. Patient died on 01/04/2008.

Gemzar Side Effects Report #6045810-2
Gemzar side effect was reported by a Physician from JAPAN on May 27, 2008. Female patient, weighting 110.2 lb, was diagnosed with bile duct cancer, prophylaxis and was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, metastases to lung, metastases to peritoneum. Gemzar dosage: 1300 MG, OTHER. During the same period patient was treated with SEROTONE, DECADRON, RINDERON, MYSLEE, THYRADIN S, LOXONIN, CYTOTEC, TAKEPRON. Patient died on 01/04/2008.

Gemzar Side Effects Report #5224276-6
Gemzar side effect was reported by a Physician from JAPAN on Jan 23, 2007. Male patient was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, liver disorder, malignant neoplasm progression, platelet count decreased. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with IRINOTECAN. Patient died.

Gemzar Side Effects Report #5224296-1
Gemzar side effect was reported by a Physician from JAPAN on Jan 23, 2007. Male patient was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, liver disorder, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with IRINOTECAN. Patient died.

Gemzar Side Effects Report #5237505-X
Gemzar side effect was reported by a Physician from JAPAN on Feb 05, 2007. Male patient was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, liver disorder, malignant neoplasm progression. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with IRINOTECAN. Patient died.

Gemzar Side Effects Report #5237520-6
Gemzar side effect was reported by a Physician from JAPAN on Feb 05, 2007. Male patient was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, liver disorder, malignant neoplasm progression, platelet count decreased. Gemzar dosage: 1000 MG/M2, OTHER. During the same period patient was treated with IRINOTECAN. Patient died.


Gemzar Side Effects Report #5977820-5
Gemzar side effect was reported by a Physician from FRANCE on Nov 27, 2008. Male patient was treated with Gemzar. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, peripheral ischaemia. Gemzar dosage: 1775 MG/INFUSION (DAY ONE AND DAY EIGHT OF 21 DAY CYCLE). During the same period patient was treated with HYTACAND, ZYLORIC, ISOPTIN, RABEPRAZOLE, PRAVASTATIN. Patient was hospitalized. Patient died on 09/22/2008.